Press review: US election criticism and Belgium against CETAPress Review October 25, 13:00
Russian deputy PM: Agreements on crude production cap to stabilize oil sector investmentsBusiness & Economy October 25, 12:46
Russia ready to extend Turkish stream after written guarantees from EU — LavrovBusiness & Economy October 25, 12:34
Pablo Picasso paintings come to lifeSociety & Culture October 25, 12:31
Minsk confirms it is ready to host Contact Group meeting October 26World October 25, 12:09
Moscow surprised as Germany places politics above economy — LavrovRussian Politics & Diplomacy October 25, 12:03
Terrorists cutting off Aleppo residents from humanitarian corridorsWorld October 25, 11:32
Animal abuse probe opened as 2 dolphins, seal and sea lion cub die in Primorye aquariumSociety & Culture October 25, 11:01
South Ossetia's military may be allowed to serve in the Russian army — defense ministerMilitary & Defense October 25, 10:37
MOSCOW, March 17. /TASS/. The World Anti-Doping Agency (WADA) still has not answered to the Latvian pharmaceutical firm Grindex why the company’s produced mildronate was included in the list of the banned substances, Grindex spokeswoman Laila Klavina told TASS on Thursday.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016.
"It was last summer, when Grindex jointly with the Anti-Doping Department of the Latvian State Center for Athletics Medicine provided WADA with all arguments, proof and reasoning why the drug should not be included in the list of the banned substances," Klavina said in an interview with TASS.
"There was still no information from WADA last autumn, when it became obvious that meldonium would be on the list," she added. "All we know as of now is that meldonium on the list of the banned substances. Meanwhile, there is still no response from WADA."
Last week Grindex announced on its website that "Mildronate is widely used in the clinical practice."
"During increased physical activity, it restores the oxygen balance of tissue cells as well as it activates the metabolic processes that results in lower requirements of oxygen consumption for energy production," according to Grindex. "Mildronate is widely recognized by health care professionals and patients, and this may include athletes as well."
Russian sports was hit last week by a new case in a chain of doping-related scandals after some of the country’s athletes tested positive for banned substance meldonium.
After the drug meldonium (mildronate) was included in WADA’s list of banned substances a number of Russian athletes tested positive for the banned substance.
Those who have proved to have used meldonium since are cyclist Eduard Vorganov, figure skater Yekaterina Bobrova, tennis player Maria Sharapova, skater Pavel Kulizhnikov, short-track skaters Semion Elistratov and Ekaterina Konstantinova, volleyball player Aleksandr Markin and biathlete Eduard Latypov.
The number of athletes from Russia as well as worldwide testing positive for banned meldonium keeps rising.
The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).